top of page
< Back

Pivotal study published in the prestigious American Heart Association journal “Circulation”

22 Dec 2023

contact@polygenrx.com

Newcastle, NSW, Australia

Keywords: PolygenRx; precision medicine; companion diagnostics; targeted therapy; polygenic architecture; drug development, drug discovery; drug repurposing; pharmaceuticals; chronic disease; genetics; pharmagenic enrichment score (PES).

© 2022 PolygenRX

Website design and development by Rosalie Grierson-Burgess

Connect With Us On:

  • LinkedIn
  • Twitter
bottom of page